AAP
PLSE icon

Arax Advisory Partners’s Pulse Biosciences PLSE Stock Holding History

Arax Advisory Partners’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.46K Buy
253
+9
+4% +$166 ﹤0.01% 2737
2025
Q4 		$3.35K Sell
244
-81
-25% -$1.26K ﹤0.01% 3049
2025
Q3 		$5.75K Buy
+325
New +$5.14K ﹤0.01% 2827
2025
Q1 		– Sell
-278
Closed -$4.84K – 2957
2024
Q4 		$4.84K Buy
278
+34
+14% +$599 ﹤0.01% 1753
2024
Q3 		$4.28K Hold
244
– – ﹤0.01% 1784
2024
Q2 		$2.73K Buy
+244
New +$2.3K ﹤0.01% 1846

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Arax Advisory Partners's PLSE Position: Q1 2026 in Review

Arax Advisory Partners increased its Pulse Biosciences (PLSE) stake by 3.7% in Q1 2026, buying an estimated $166 and bringing the position to 253 shares worth $5.46K. The position accounts for ﹤0.01% of the portfolio, ranked #2737.

Arax Advisory Partners first reported a position in PLSE in Q2 2024 and has held it in 6 quarters since. The position peaked at $5.75K in Q3 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Arax Advisory Partners held 253 shares of Pulse Biosciences worth $5.46K as of Q1 2026.
  • Arax Advisory Partners bought 9 Pulse Biosciences shares in Q1 2026, an estimated $166.
  • Pulse Biosciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2737 holding.
  • Arax Advisory Partners first reported a position in Pulse Biosciences in Q2 2024 and has held it in 6 quarters since.
  • Arax Advisory Partners's Pulse Biosciences position peaked at $5.75K in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.